Prostate Cancer Diagnostics Market Analysis
Global Prostate Cancer Diagnostics Market reached a value of US$ 4.17 Billion in 2023 and is expected to grow at a CAGR of 12.35% from 2024 to 2032, reaching an estimated US$ 11.89 Billion by 2032.
Prostate cancer is a type of cancer that develops in the prostate gland, which is part of the male reproductive system. It is one of the most common cancers among men. Symptoms may include difficulty urinating, blood in the urine or semen, erectile dysfunction, and pain in the hips, back, or chest. Early detection through regular screenings and treatment options like surgery, radiation therapy, and hormone therapy can improve outcomes. The increasing prevalence of prostate cancer is driving the market's growth. According to a publication by the American Society of Clinical Oncology (ASCO) in March 2023, prostate cancer is the most common cancer among males. It is estimated that 288,300 males will be diagnosed with prostate cancer in 2023.
Request